A novel drug for bloodstream infections, code-named VRP-034 and currently in the development stage pending final trials and ...

Ontario County is rolling out a new initiative aimed at revitalizing vacant and underused rental properties, with a series of public seminars scheduled to introduce the Vacant Rental Program (VRP).

Shares of Venus Remedies rose 14.3% to ₹356.65 after the US FDA granted QIDP designation to its product VRP-034, targeting ...

The QIDP status, granted by USFDA makes VRP-034 eligible for regulatory benefits including priority FDA review, potential ...

Index funds provide exposure to credit and duration risk but don't take advantage of Volatility Risk Premium. The Overlay ...

The Venus Remedies investigational product, VRP-034, has been granted QIDP designation by the US FDA for the treatment of bloodstream infections caused by polymyxin B (PMB)-susceptible strains in adul ...

VRP looks a good choice for investors seeking exposure in preferred stocks with a relative low risk of capital decay compared to peers. However, inflation may take its toll and the heavy weight of ...

Venus Remedies’ novel polymyxin B formulation, VRP-034 gets US FDA QIDP designation: Our Bureau, Bengaluru Thursday, April 17, 2025, 12:15 Hrs [IST] Venus Remedies’ investigat ...

India’s Venus Remedies has secured Qualified Infectious Disease Product designation from the United States Food and Drug ...

Gold futures rose to fresh highs on safe-haven demand and a weaker U.S. dollar. Futures climbed as high as $3,336.0/oz. Uncertainty around President Trump's shifting tariff policy has investors ...

Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education ...